Li Fan

Prof. Li Fan

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Biomaterials
Verified
Journal Article
Closed access
WZWenli zhang
Wenli zhang
XZXiaofeng Zhang
Xiaofeng Zhang
YSYingli Shen
Yingli Shen
FSFeng Shi
Feng Shi
CSChaojun Song
Chaojun Song
HLHongbing Lu
Hongbing Lu

15 June 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
Wujun XuWujun Xu
Wujun Xu
KTKonstantin Tamarov
Konstantin Tamarov
LFLi Fan
Li Fan
SGSari Granroth
Sari Granroth
JRJimi Rantanen
Jimi Rantanen
VLVesa-Pekka Lehto
Vesa-Pekka Lehto
Porous silicon (PSi) has attracted wide interest as a potential material for various fields of nanomedicine. However, until now, the application of PSi in photothermal therapy has not been successful due to its low photothermal conversion efficiency. In the present study, biodegradable black PSi (BPSi) nanoparticles were designed and prepared via a high yield and simple reaction. The BPSi nanoparticles possessed a low bandgap of 1.34 eV, a high extinction coefficient of 13.2 L g-1 cm-1 at 808 nm, a high photothermal conversion efficiency of 33.6%, good photostability and a large surface area. The nanoparticles had not only excellent photothermal properties surpassing most of the present inorganic photothermal conversion agents (PCAs), but they also displayed good biodegradability, a common problem encountered with the inorganic PCAs. The functionality of the BPSi nanoparticles in photothermal therapy was verified in tumor-bearing mice in vivo. These results showed clearly that the photothermal treatment was highly efficient to inhibit tumor growth. The designed PCA material of BPSi is robust, easy to prepare, biocompatible, therapeutically extremely efficient, and it can be integrated with several other functionalities based on simple silicon chemistry.

4 May 2022 in Bioorganic Chemistry
Verified
Journal Article
Closed access
JXJia-Yue Xi
Jia-Yue Xi
RZRu-Yue Zhang
Ru-Yue Zhang
KCKe Chen
Ke Chen
LYLin Yao
Lin Yao
MLMu-Qiong Li
Mu-Qiong Li
LFLi Fan
Li Fan

3 October 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MLMiao Liu
Miao Liu
ZSZiyu Shi
Ziyu Shi
XWXiao Wang
Xiao Wang
YZYanting Zhang
Yanting Zhang
XMXiulan Mo
Xiulan Mo
FSFeng Shi
Feng Shi
We design and synthesize an ultrasmall and high biocompatibility NH 2 -PEGylated-NaGdF 4 :Yb,Er, X % Lu nanoparticles with enhanced red upconversion luminescence and CT contrast performance.

26 August 2021 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
CLChengfei Liu
Chengfei Liu
MLMuqiong Li
Muqiong Li
PLPengxiang Li
Pengxiang Li
YBYang Bai
Yang Bai
JPJun Pang
Jun Pang
WTWei Tian
Wei Tian

25 September 2015 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
LFLi Fan
Li Fan
QYQian Yang
Qian Yang
JTJiali Tan
Jiali Tan
YQYoubei Qiao
Youbei Qiao
QWQiaofeng Wang
Qiaofeng Wang
YZYongsheng Zhang
Yongsheng Zhang
Background: Dual loading drug delivery system with tumor targeting efficacy and sequential release function provides a promising platform for anticancer drug delivery. Herein, we established a novel AuCOOH@FACS nanogel system for co-delivery miR-218 mimics (as bio-drug) and Temozolomide(as chemo-drug). Methods: DLS and TEM were employed to determine the characteristics of particles and nanogels. The cell viability was calculated for study synergistic effect of both drugs coadministration and in nanogel forms. The amounts of Au uptake were measured by ICP-MS in cell and tumors to quantify the targeting drug delivery efficacy. Tumor weight and mice weight were investigated to study the targeting antitumor efficacy of nanogel system. Results: The results revealed that using AuCOOH@FACS nanogel as delivery vehicles, drugs could be targeting delivery to tumor site, the intracellular uptake is enhanced to a greater extent, and significant antitumor efficacy is fold increase compared with free drug administration group, without noticeable system cytotoxicity. Conclusions: This system offers an efficient approach to cancer therapy and holds significant potential to improve the treatment of cancer in the future.